Table 1.
Demographic characteristics of the study populations. Significant p-values are underlined.
| Characteristic | AMI (n = 101) | Control (n = 66) | p-Value |
|---|---|---|---|
| Demographic variables | |||
| Age (Median (Min–Max)) | 57 (33–81) |
54.5 (40–71) |
2.7 × 10−1 |
| Gender (Female) (%) | 12.9 | 40.9 | 6.3 × 10−4 |
| Smoking status (%) | |||
| Non | 37.6 | 90.9 | |
| Current | 35.6 | 3.0 | |
| Ex | 26.7 | 6.1 | |
| Race (%) | 1.0 × 10−14 | ||
| Chinese | 27.7 | 60.6 | |
| Malay | 21.8 | 9.1 | |
| Indian | 6.9 | 30.3 | |
| Others | 43.6 | 0.0 | |
| Cardiovascular risk factors based on medical history | |||
| Prior MI (%) | 4.0 | 0.0 | 1.5 × 10−1 |
| FH of CHD (%) | 20.8 | 10.6 | 9.4 × 10−2 |
| Diabetes (%) | 20.8 | 12.1 | 2.1 × 10−1 |
| Hypertension (%) | 43.6 | 28.8 | 7.2 × 10−2 |
| Dyslipidemia (%) | 42.6 | 77.3 | 3.3 × 10−5 |
| Other cardiovascular risk factors, predictors of AMI and adverse events (Median [Min–Max]) | |||
| DBP, mm Hg | 83.50 (39–138) |
74 (53–107) |
1.6 × 10−4 |
| SBP, mm Hg | 140 (74–241) |
127 (97–175) |
8.2 × 10−6 |
| Triglyceride, mmol/L | 1.50 (0.35–5.58) |
1.38 (0.37–4.37) |
5.1 × 10−1 |
| Cholesterol, mmol/L | 5.01 (3.20–7.40) |
5.32 (4.05–7.37) |
1.5 × 10−3 |
| HDL-C, mmol/L | 1.03 (0.67–9.40) |
1.34 (0.80–2.31) |
6.6 × 10−10 |
| LDL-C, mmol/L | 3.20 (1.60–5.51) |
3.27 (2.19–5.25) |
1.1 × 10−1 |
| WBC, ×109/L | 10.85 (4.40–25.90) |
5.50 (2.60–9.0) |
1.5 × 10−20 |
| Platelet, ×109/L | 250.5 (134–649) |
258 (165–599) |
3.8 × 10−1 |
| Creatinine, mmol/L | 88.5 (51–142) |
69 (42–97) |
3.9 × 10−13 |
| hsTnT, pg/mL | 1726 (62–9819) |
6 (3–18) |
8.8 × 10−28 |
| NTproBNP, pg/mL | 718 (68–6819) |
36 (7–150) |
3.0 × 10−27 |